Latest filing published 03 Dec 2018 for INVO Fertility, Inc., €22k.
Filing timeline
BuySaleInsider track record
Claude Ranoux: trading record in brief
All filings by Claude Ranoux on record concern INVO Fertility, Inc. We count 54 filings; the first trade dates from 19 June 2017 and the latest from 3 December 2018.
Sales make up the whole of the open-market record (51 sales, €143k). Other entries cover 1 share grant. In 2018 alone, the filings show no purchases and 41 sales.
On 3 December 2018 came the latest disclosure, an open-market sale for €22k in INVO Fertility, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Claude Ranoux
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500,000 shares@ US$0.055.6% of flowINVO Bioscience common stockSEC:0001479791-18-000020:1
- 1,000,000 sharesINVO Bioscience common stockSEC:0001479791-18-000020:0
- 910,878 shares@ US$0.3979.1% of flowrestricted common shares of INVO BioscienceSEC:0001479791-18-000019:0
- 1,000 shares@ US$0.120.0% of flowINVO Bioscience Common StockSEC:0001479791-18-000018:0
- 12,642 shares@ US$0.190.4% of flowINVO Bioscience Common StockSEC:0001479791-18-000018:1
- 2,000 shares@ US$0.180.1% of flowINVO Bioscience Common StockSEC:0001479791-18-000017:0
- 100 shares@ US$0.180.0% of flowINVO Bioscience Common StockSEC:0001479791-18-000016:0
- 100 shares@ US$0.11140.0% of flowINVO Bioscience Common StockSEC:0001479791-18-000015:0
- 23,260 shares@ US$0.110.5% of flowINVO Bioscience Common StockSEC:0001479791-18-000015:1
- 25,000 shares@ US$0.1080.5% of flowINVO Bioscience Common StockSEC:0001479791-18-000015:2
- 28,662 shares@ US$0.11140.6% of flowINVO Bioscience Common StockSEC:0001479791-18-000015:3
- 10,000 shares@ US$0.1120.2% of flowINVO Bioscience Common StockSEC:0001479791-18-000015:4
- 5,000 shares@ US$0.1140.1% of flowINVO Bioscience Common StockSEC:0001479791-18-000015:5
- 17,900 shares@ US$0.120.4% of flowINVO Bioscience Common StockSEC:0001479791-18-000015:6
- 12,400 shares@ US$0.120.3% of flowINVO Bioscience Common StockSEC:0001479791-18-000015:7
- 100 shares@ US$0.110.0% of flowINVO Bioscience Common StockSEC:0001479791-18-000014:0
- 11,050 shares@ US$0.110.2% of flowINVO Bioscience Common StockSEC:0001479791-18-000014:1
- 2,740 shares@ US$0.110.1% of flowINVO Bioscience Common StockSEC:0001479791-18-000014:2
- 1,000 shares@ US$0.1150.0% of flowINVO Bioscience Common StockSEC:0001479791-18-000013:0
- 11,808 shares@ US$0.110.2% of flowINVO Bioscience Common StockSEC:0001479791-18-000013:1
- 100 shares@ US$0.1120.0% of flowINVO Bioscience Common StockSEC:0001479791-18-000012:0
- 16,015 shares@ US$0.11150.3% of flowINVO Bioscience Common StockSEC:0001479791-18-000012:1
- 100 shares@ US$0.1170.0% of flowINVO Bioscience Common StockSEC:0001479791-18-000011:0
- 9,500 shares@ US$0.1170.2% of flowINVO Bioscience Common StockSEC:0001479791-18-000011:1
- 1,100 shares@ US$0.1160.0% of flowINVO Bioscience Common StockSEC:0001479791-18-000011:2
25 of 54 declarations